A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumors

Gerhardt Attard, Maja J. De Jonge, Gerhard Zugmaier et al.|Journal of Clinical Oncology|2005

Cited by 8